Review: Acetylation Links Autophagy and Senescence in Metabolic Disease
This review proposes lysine acetylation as a nutrient-sensitive regulator that, under metabolic stress, suppresses autophagy while stabilizing cellular senescence; it emphasizes the mTORC1-p300-SIRT1 axis and discusses liver and adipose tissue. [1]
Automatic summary · not editorially reviewed
The key findings
The review links chronic nutrient overload in metabolic diseases to autophagy and cellular senescence, with lysine acetylation proposed as a nutrient-sensitive regulator of both. [1]
The review reports mechanistic evidence that acetylation inhibits autophagy at multiple checkpoints while reinforcing senescence through chromatin hyperacetylation and effectors such as NF-κB, p53 and FOXO. [1]
The mTORC1-p300-SIRT1 axis is presented as the primary integration hub, and strategies such as acetyltransferase inhibition or sirtuin activation are described as emerging. [1]
The source at a glance
- Study type / format
- Review (abstract only)
- Population / context
- Metabolic tissues and diseases discussed in a review, including obesity, type 2 diabetes and steatotic liver disease
- Summary based on
- Study abstract
- Publication status
- Preprint · peer-review status not confirmed
- Original publication
- July 3, 2026
Metabolic stress, autophagy and senescence in the review
The review addresses metabolic diseases such as obesity, type 2 diabetes and metabolic dysfunction-associated steatotic liver disease, described as arising from chronic nutrient overload. It frames two stress-adaptive programs: autophagy, described as lysosomal recycling and organelle quality control, and cellular senescence, described as a tissue repair system that becomes harmful when persistent, with stable growth arrest and inflammatory remodeling via the senescence-associated secretory phenotype. The authors present lysine acetylation as a nutrient-sensitive regulator of both processes.
Supporting source [1]
Proposed double effect via mTORC1-p300-SIRT1
According to the review, acetylation dynamics depend on acetyl-CoA availability and the NAD+-dependent deacetylation capacity of sirtuins, so metabolic stress shifts the balance between acetyltransferases such as p300/CBP and deacetylases. This shift is proposed to cause a "double blow": suppressed autophagic flux together with epigenetic stabilization of the senescent state. The review reports mechanistic evidence that acetylation inhibits autophagy at multiple checkpoints, from core autophagy protein activity to lysosomal biogenesis, while reinforcing senescence through chromatin hyperacetylation and non-histone effectors such as NF-κB, p53 and FOXO proteins. The mTORC1-p300-SIRT1 axis is presented as the main integration hub.
Supporting source [1]
Tissue focus and proposed strategies, not tested outcomes
The review discusses tissue-specific manifestations in the liver, adipose tissue and other metabolic organs. It highlights emerging therapeutic strategies such as inhibiting acetyltransferases or activating sirtuins, aimed at restoring the acetylation balance to improve autophagic competence while restraining senescence-driven metabolic decline. These are described as emerging strategies, not as tested treatments or established outcomes.
Supporting source [1]
How to interpret this
This is an abstract of a review; the full text was not reviewed. It synthesizes mechanistic evidence and proposes therapeutic strategies but reports no primary study design, sample, follow-up or tested outcomes. Proposed strategies are not established treatments.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Naz F, Luo P, Gill RA, Wang X, Ruan W, Feng C, Wang F. · europepmc.org · July 3, 2026